Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Retrospective, Medical Record Review Of The Effectiveness Of Lanreotide Following Treatment With Octreotide In Patients With Neuroendocrine Tumors

NCT03112694 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03112694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03112694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Retrospective, Medical Record Review Of The Effectiveness Of Lanreotide Following Treatment With Octreotide In Patients With Neuroendocrine Tumors
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
April 4, 2017
Completion date
November 2, 2017
Enrollment
93 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors